Adeno-associated virus vectors for gene therapy: more pros than cons?

By Monahan P.E.   Samulski R.J.  

Molecular Medicine Today, Vol. 6, Iss. 11, 2000-11 ,pp. : 433-440

Elsevier

Access to resources Recommend Favorite

Immune Response Against Gene Therapy Vectors: Influence of Synovial Fluid on Adeno-Associated Virus Mediated Gene Transfer to Chondrocytes

By Cottard Virginie   Valvason Chiara   Falgarone Géraldine   Lutomski Didier   Boissier Marie-Christophe   Bessis Natacha  

Journal of Clinical Immunology, Vol. 24, Iss. 2, 2004-03 ,pp. : 162-169

Springer Publishing Company

Access to resources Recommend Favorite

Enhancement of gene transfer with recombinant adeno-associated virus (rAAV) vectors into primary B-cell chronic lymphocytic leukemia cells by CpG-oligodeoxynucleotides

By Theiss H.D.   Kofler D.M.   Buning H.   Aldenhoff A.-L.   Kaess B.   Decker T.   Baumert J.   Hallek M.   Wendtner C.-M.  

Experimental Hematology, Vol. 31, Iss. 12, 2003-12 ,pp. : 1223-1229

Elsevier

Access to resources Recommend Favorite

Adeno-Associated Virus Is Associated with a Lower Risk of High-Grade Cervical Neoplasia

By Coker A.L.   Russell R.B.   Bond S.M.   Pirisi L.   Liu Y.   Mane M.   Kokorina N.   Gerasimova T.   Hermonat P.L.  

Experimental and Molecular Pathology, Vol. 70, Iss. 2, 2001-04 ,pp. : 83-89

Elsevier

Access to resources Recommend Favorite

Induction of T cell immunity by cutaneous genetic immunization with recombinant lentivector

By He Yukai   Falo Louis  

Immunologic Research, Vol. 36, Iss. 1-3, 2006-02 ,pp. : 101-117

Humana Press, Inc

Access to resources Recommend Favorite